|
|
Bristol Myers Squibb Co (BMY) |
|
|
|
| |
BMY's Revenue Growth by Quarter and Year
Bristol Myers Squibb Co's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| BMY Revenue (in millions $) |
FY 2021 |
FY 2020 |
FY 2019 |
FY 2018 |
| IV Quarter |
December |
-
|
11,068.00
|
7,945.00
|
5,973.00
|
| III Quarter |
September |
-
|
10,540.00
|
6,007.00
|
5,691.00
|
| II Quarter |
June |
-
|
10,129.00
|
6,273.00
|
5,704.00
|
| I Quarter |
March |
11,073.00
|
10,781.00
|
5,920.00
|
5,193.00
|
| FY |
|
11,073.00
|
42,518.00
|
26,145.00
|
22,561.00
|
| BMY Revenue first quarter 2021 Y/Y Growth Comment |
Bristol Myers Squibb Co achieved in the first quarter, above Company average Revenue improvement of 2.71% year on year, to $ 11,073.00 millions.
Looking into first quarter results within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Revenue growth. While Bristol Myers Squibb Co' s Revenue increase of 2.71% ranks overall at the positon no. 361 in the first quarter.
|
| BMY Revenue ( Y/Y Growth %) |
2021
|
2020 |
2019 |
2018 |
| IV Quarter |
December |
- |
39.31 % |
33.02 % |
9.62 % |
| III Quarter |
September |
- |
75.46 % |
5.55 % |
8.32 % |
| II Quarter |
June |
- |
61.47 % |
9.98 % |
10.89 % |
| I Quarter |
March |
2.71 % |
82.11 % |
14 % |
5.36 % |
| FY |
|
- |
62.62 % |
15.89 % |
8.59 % |
BMY Revenue (Quarter on Quarter Growth %) |
2021
|
2020 |
2019 |
2018 |
| IV Quarter |
December |
- |
5.01 % |
32.26 % |
4.96 % |
| III Quarter |
September |
- |
4.06 % |
-4.24 % |
-0.23 % |
| II Quarter |
June |
- |
-6.05 % |
5.96 % |
9.84 % |
| I Quarter |
March |
0.05 % |
35.7 % |
-0.89 % |
-4.7 % |
| FY (Year on Year) |
|
- |
62.62 % |
15.89 % |
8.59 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 18.59 % |
1.22 % |
-8.06 % |
| (Mar 31 2020) |
|
(March 31, 2013) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 18.59 % |
1.22 % |
-8.06 % |
| (Mar 31 2020) |
|
(March 31, 2013) |
|
| Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021 |
Bristol Myers Squibb Co's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 35.7 % |
1.5 % |
-15.91 % |
| (Mar 31 2020) |
|
|
| BMY's I. Quarter Q/Q Revenue Comment |
Bristol Myers Squibb Co achieved in the I. Quarter 2021 below company average Revenue growth of 0.05% quarter on quarter, to $ 11,073.00 millions.
Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Bristol Myers Squibb Co's Revenue growth quarter on quarter, overall rank is 292. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 35.7 % |
1.5 % |
-15.91 % |
| (Mar 31 2020) |
|
|
| BMY's I. Quarter Q/Q Revenue Comment |
Bristol Myers Squibb Co achieved in the I. Quarter 2021 below company average Revenue growth of 0.05% quarter on quarter, to $ 11,073.00 millions.
Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Bristol Myers Squibb Co's Revenue growth quarter on quarter, overall rank is 292. |
|
Bristol Myers Squibb Co's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Mar 31 2021) |
12 Months Ending
(Dec 31 2020) |
12 Months Ending
(Sep 30 2020) |
12 Months Ending
(Jun 30 2020) |
12 Months Ending
(Mar 31 2020) |
| Cumulative Revenue 12 Months Ending |
$ 42,810.00 |
$ 42,518.00 |
$ 39,395.00 |
$ 34,862.00 |
$ 31,006.00 |
| Y / Y Revenue Growth (TTM) |
38.07 % |
62.62 % |
62.97 % |
46.13 % |
33.14 % |
| Year on Year Revenue Growth Overall
Ranking |
# 45 |
# 159 |
# 295 |
# 354 |
# 190 |
| Seqeuential Revenue Change (TTM) |
0.69 % |
7.93 % |
13 % |
12.44 % |
18.59 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 361 |
# 478 |
# 366 |
# 297 |
# 202 |
| Cumulative Revenue growth
Comment |
Assuming the Bristol Myers Squibb Co's fiscal year would have ended in Mar 31 2021, Bristol Myers Squibb Co would have reprted above average annual Revenue rise of 38.07% year on year, of $ 42,810 millions.
This marks a slow-down of the companys growth trends and from the 62.62% increase in Dec 31 2020.
Among companies within the Healthcare sector 8 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 45, from total ranking in previous quarter at 159. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
18.59 % |
1.22 % |
-8.06 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
62.97 % |
5.72 % |
-24.59 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 6 |
| Sector |
# 30 |
| S&P 500 |
# 361 |
|
| Cumulative Revenue growth
Comment |
Assuming the Bristol Myers Squibb Co's fiscal year would have ended in Mar 31 2021, Bristol Myers Squibb Co would have reprted above average annual Revenue rise of 38.07% year on year, of $ 42,810 millions.
This marks a slow-down of the companys growth trends and from the 62.62% increase in Dec 31 2020.
Among companies within the Healthcare sector 8 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 45, from total ranking in previous quarter at 159. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
18.59 % |
1.22 % |
-8.06 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
62.97 % |
5.72 % |
-24.59 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 6 |
| Sector |
# 30 |
| S&P 500 |
# 361 |
|
4.74%